NEW YORK (GenomeWeb News) — Shares in Compugen slid 5.53 percent, or $.16, to $2.83 in mid-afternoon trading today after the company reported a 20-percent jump in R&D spending and a 12-percent jump in net loss atop weak revenue.
 
As GenomeWeb News reported this morning, Compugen also said it may need to raise additional cash by the middle of 2009 if it continues spending as it has been.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.